FDA product code DXZ: Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene
DXZ is the FDA product code for patch, pledget and intracardiac, petp, ptfe, polypropylene. It is a Class II device, regulated under 21 CFR 870.3470 and reviewed by the Cardiovascular panel. FDA has cleared 90 510(k) submissions under DXZ, 1 in the last five years, from 41 different applicants. The average 510(k) review took 137 days (median 90); 393 days on average over the last three years. FDA has posted 21 recalls for DXZ devices, 6 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene |
| Device class | Class II |
| Regulation | 21 CFR 870.3470 |
| Review panel | CV — Cardiovascular |
| Medical specialty | Cardiovascular |
| Premarket route | 510(k) |
| Implant | Yes |
510(k) clearances per year for DXZ
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 1 | 182 |
| 2020 | 1 | 90 |
| 2025 | 1 | 393 |
Compare with all 510(k) review times · Search every DXZ clearance
Top DXZ applicants
| Applicant | Clearances | Latest |
|---|---|---|
| W. L. Gore & Associates, Inc. | 13 | 2001-09-20 |
| Chase Medical, Inc. | 7 | 2002-09-20 |
| Cormatrix Cardiovascular, Inc. | 5 | 2016-02-04 |
| Meadox Medicals, Div. Boston Scientific Corp. | 5 | 1996-09-10 |
| Bio-Vascular, Inc. | 4 | 1998-11-12 |
36 more applicants have DXZ clearances. See the full list in Caduvo.
Most recent DXZ clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K240775 | Tamabio | PeriBeam® Pericardial Membrane | 2025-04-18 | 393 |
| K200955 | Vascutek, Ltd. | Vascutek Gelseal Patch, Vascutek Gelsoft Patch, Vascutek Thin Wall Carotid Patch | 2020-07-08 | 90 |
| K162506 | Cryolife, Inc. | PhotoFix Decellularized Bovine Pericardium | 2017-03-09 | 182 |
| K162579 | Admedus Regen Pty, Ltd. | VascuCel | 2016-10-14 | 29 |
| K152127 | Cormatrix Cardiovascular, Inc. | CorMatrix Tyke | 2016-02-04 | 188 |
Recalls for DXZ devices
21 product recalls in 18 recall events; 6 initiated in the last five years and 6 still open. Most recent: 2026-09-18.
| Year | Recalls |
|---|---|
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Frequently asked questions
What is FDA product code DXZ?
DXZ is the FDA product code for patch, pledget and intracardiac, petp, ptfe, polypropylene. It is a Class II device, regulated under 21 CFR 870.3470 and reviewed by the Cardiovascular panel.
What device class is DXZ?
Class II, regulation 21 CFR 870.3470. Typical premarket route: 510(k).
How long does a 510(k) take for product code DXZ?
Across 90 cleared submissions the average was 137 days from receipt to decision (median 90).
Which companies have the most DXZ clearances?
W. L. Gore & Associates, Inc. (13); Chase Medical, Inc. (7); Cormatrix Cardiovascular, Inc. (5); Meadox Medicals, Div. Boston Scientific Corp. (5); Bio-Vascular, Inc. (4).
Have DXZ devices been recalled?
Yes: 21 product recalls across 18 recall events; the most recent began 2026-09-18.
Next steps
- Run an FDA pathway report with predicate devices for product code DXZ
- Run a recall and safety report across every DXZ manufacturer
- Watch product code DXZ for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times